| Dr Olivier Leroy Stenotrophomonas maltophilia is an emerging nosocomial pathogen more and more often responsible for respiratory tract infections. It is intrinsically resistant … Suite
| Dr Olivier Leroy The utility of therapeutic drug monitoring (TDM) is pronounced in drugs with wide interpatient pharmacokinetic variability, a demonstrated relationship between … Suite
| Dr Jean-Pierre Bru The objective was to better determine the β-lactam exposure associated with positive clinical outcomes for Gram-negative blood stream infection (BSI) … Suite
| Dr Jean-Pierre Bru This randomised, controlled, double-blind, non-inferiority trial was conducted at 263 hospitals in 34 countries. Eligible patients were adults, undergoing mechanical … Suite
| Pr Pierre Tattevin Vancomycin has been associated with DRESS syndrome (Drug Reaction with Eosinophilia and Systemic Symptoms), a rare but potentially fatal hypersensitivity … Suite
| Dr Jean-Pierre Bru The aim of this study (conducted in Beijing) was to evaluate whether combination of point-of-care test (POCT) and routine real-time … Suite
| Dr Jean-Pierre Bru Macrolide-resistance in Mycoplasma genitalium (MG) exceeds 50% in many regions and quinolone-resistance is increasing. The aim of the study was … Suite
| Dr Jean-Pierre Bru Daptomycin has interesting microbiological and PKPD characteristics for the treatment of gram+ Infectious Endocarditis (IE). This work provides an experience … Suite
| Dr Jean-Pierre Bru Ceftazidime/avibactam, display in vitro activity against strains producing class-A-carbapenemases, including Klebsiella pneumoniae (KPC), as well as some class-D-carbapenemases, Some recent … Suite
| Dr Olivier Leroy The presence of an aortic valve prosthesis is considered as a risk factor for infectious endocarditis (IE). Although Transcatheter Aortic … Suite
